Amandine Amalric

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 12

Top Topics

Oxide Nanoparticles

Cancer Stem Cells

Top Venues

Cancer research communications

Analytical chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression. Cancer research communications (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. Cancer research communications 4 (5) (2024)
Amandine Amalric, Aurore Attina, Amandine Bastide, Marion Buffard, Stéphanie Mateus, Chris Planque, Eric Rivals, Christophe Hirtz, Alexandre David
Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation. Analytical chemistry 96 (5) (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. Cancer research communications 4 (5) (2024)
Amandine Amalric, Aurore Attina, Amandine Bastide, Marion Buffard, Stéphanie Mateus, Chris Planque, Eric Rivals, Christophe Hirtz, Alexandre David
Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation. Analytical chemistry 96 (5) (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. Cancer research communications 4 (5) (2024)
Amandine Amalric, Aurore Attina, Amandine Bastide, Marion Buffard, Stéphanie Mateus, Chris Planque, Eric Rivals, Christophe Hirtz, Alexandre David
Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation. Analytical chemistry 96 (5) (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression. Cancer research communications (2024)
Amandine Amalric, Aurore Attina, Amandine Bastide, Marion Buffard, Stéphanie Mateus, Chris Planque, Eric Rivals, Christophe Hirtz, Alexandre David
Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation. Analytical chemistry (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De Novo Purine Metabolism is a Metabolic Vulnerability of Cancers with Low p16 Expression. Cancer research communications 4 (5) (2024)
Naveen Kumar Tangudu, Raquel Buj, Hui Wang, Jiefei Wang, Aidan R Cole, Apoorva Uboveja, Richard Fang, Amandine Amalric, Baixue Yang, Adam Chatoff, Claudia V Crispim, Peter Sajjakulnukit, Maureen A Lyons, Kristine L Cooper, Nadine Hempel, Costas Andreas Lyssiotis, Uma R Chandran, Nathaniel W Snyder, Katherine Marie Aird
De novo purine metabolism is a metabolic vulnerability of cancers with low p16 expression. Cancer research communications (2024)
Amandine Amalric, Aurore Attina, Amandine Bastide, Marion Buffard, Stéphanie Mateus, Chris Planque, Eric Rivals, Christophe Hirtz, Alexandre David
Mass Spectrometry-Based Pipeline for Identifying RNA Modifications Involved in a Functional Process: Application to Cancer Cell Adaptation. Analytical chemistry 96 (5) (2024)